Found: 115
Select item for more details and to access through your institution.
Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme.
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 7, p. 1087, doi. 10.1111/imj.16348
- By:
- Publication type:
- Article
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1305720
- By:
- Publication type:
- Article
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46008-1
- By:
- Publication type:
- Article
Accuracy of oncologists' estimates of expected survival time in advanced cancer.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad094
- By:
- Publication type:
- Article
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 14, p. 13437, doi. 10.1007/s00432-023-05149-4
- By:
- Publication type:
- Article
Metastatic primary breast neuroendocrine neoplasms: a case series.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 10, p. 1813, doi. 10.1111/imj.15961
- By:
- Publication type:
- Article
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 10, p. 1, doi. 10.1007/s00520-023-08034-5
- By:
- Publication type:
- Article
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18050, doi. 10.1002/cam4.6411
- By:
- Publication type:
- Article
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4959, doi. 10.1007/s00432-022-04404-4
- By:
- Publication type:
- Article
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 1827, doi. 10.3390/biomedicines11071827
- By:
- Publication type:
- Article
Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.
- Published in:
- Neuroendocrinology, 2023, v. 113, n. 3, p. 281, doi. 10.1159/000526848
- By:
- Publication type:
- Article
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1989, doi. 10.3390/jcm12051989
- By:
- Publication type:
- Article
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10642-7
- By:
- Publication type:
- Article
Dual [<sup>68</sup>Ga]DOTATATE and [<sup>18</sup>F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 526, doi. 10.1111/ajco.13740
- By:
- Publication type:
- Article
Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 660, doi. 10.1111/ajco.13745
- By:
- Publication type:
- Article
The role of staging laparoscopy in pancreatic adenocarcinoma and its effect on patients' survival.
- Published in:
- World Journal of Surgical Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12957-022-02803-y
- By:
- Publication type:
- Article
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 5, p. e235, doi. 10.1111/ajco.13637
- By:
- Publication type:
- Article
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221118874
- By:
- Publication type:
- Article
Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 8863, doi. 10.3390/ijms23168863
- By:
- Publication type:
- Article
The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.959637
- By:
- Publication type:
- Article
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3620, doi. 10.3390/cancers14153620
- By:
- Publication type:
- Article
Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143528
- By:
- Publication type:
- Article
Liver Isolation Oxaliplatin (LIOX): Long Term Survival from a New Locoregional Technique for Chemorefractory Patients with Colorectal Liver Metastases.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 209, doi. 10.1111/ajco.13577
- By:
- Publication type:
- Article
An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma.
- Published in:
- Lung Cancer: Targets & Therapy, 2022, v. 13, p. 1, doi. 10.2147/LCTT.S288535
- By:
- Publication type:
- Article
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 95, doi. 10.1007/s11523-022-00869-y
- By:
- Publication type:
- Article
Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 6, p. 448, doi. 10.1111/ajco.13465
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. e859, doi. 10.1016/j.cllc.2021.04.009
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Life-threatening diarrhea in neuroendocrine tumors: two case reports.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4824, doi. 10.3390/cancers13194824
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.706331
- By:
- Publication type:
- Article
The quality of clinical trials in neuroendocrine tumours; have we learnt from our mistakes? An evaluation of phase II and phase III clinical trials.
- Published in:
- Journal of Neuroendocrinology, 2021, v. 33, n. 9, p. 1, doi. 10.1111/jne.13015
- By:
- Publication type:
- Article
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2700, doi. 10.3390/jcm10122700
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 32, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.257659
- By:
- Publication type:
- Article
AS CANCER THERAPY BECOMES MORE COMPLEX, WE MUST ENHANCE OUR PROFESSIONAL STANDARDS.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 11/12, p. 950, doi. 10.1159/000504673
- By:
- Publication type:
- Article
ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. 641, doi. 10.1634/theoncologist.2020-0075
- By:
- Publication type:
- Article
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (<sup>18</sup>F) positron‐emission tomography positive intermediate grade pancreatic neuroendocrine tumors.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 3, p. 150, doi. 10.1111/ajco.13307
- By:
- Publication type:
- Article
The Economic Impact on Australian Patients with Neuroendocrine Tumours.
- Published in:
- Patient, 2020, v. 13, n. 3, p. 363, doi. 10.1007/s40271-020-00412-z
- By:
- Publication type:
- Article